A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
The Latest on: TB vaccine
via Google News
The Latest on: TB vaccine
- Afrikaans-speaking families and youth most sceptical of Covid-19 vaccineson May 12, 2021 at 5:49 am
A new study has found that individuals who trust social media as an information source were significantly more likely to exhibit Covid-19 vaccine hesitancy in SA.
- Take a 14-day gap between your flu and Covid-19 vaccines, warn health expertson May 12, 2021 at 4:37 am
The Western Cape Government Health says it will be offering the annual flu vaccination to vulnerable groups in the province.
- U.S. in touch with Indian vaccine makers: Envoyon May 11, 2021 at 10:16 am
The United States has been in contact with the Serum Institute of India and other vaccine manufacturers to boost production of vaccines against COVID-19, said the U.S. envoy to India on Tuesday.
- At 10.5% CAGR, Vaccine Adjuvants Market Revenue to Cross $ 1400.1 Million by 2027; Brandessence Market Researchon May 11, 2021 at 6:30 am
Global demand for Vaccine Adjuvants Market Size, in terms of revenue, was worth of USD 696 Million in 2020 and is expected to reach USD 1400.1 Million in 2027, growing at a CAGR of 10.5% from 2020 to ...
- Covid was just the start. Next we'll make a vaccine for canceron May 9, 2021 at 9:00 pm
Scientists are learning to harness a 'game-changing' technique that has the potential to defeat a range of humanity's deadliest foes ...
- Mumbai: Maharashtra government to relaunch BCG and MMR vaccination drives for childrenon May 7, 2021 at 11:50 am
The Maharashtra government has taken a slew of decisions to curb the COVID-19 infection and mortality rate in the 0 to 18 age group. As COVID-19 vaccine doses cannot be administered to children, the ...
- Why Does COVID-19 Testing Still Matter as Vaccines Roll Out?on May 7, 2021 at 8:45 am
The Global Fund’s Charlotte Diez-Bento explains the need to continue COVID-19 testing trace and understand the virus.
- Doctors say COVID vaccine mixing could be in our future as trials begin in US and UKon May 7, 2021 at 7:41 am
A doctor out of the UK says there's a possibility that by combining two different vaccines you can strengthen your immune response.
- The 100th Anniversary Of A Vaccine Against A Deadly Disease: Not A Cause For Celebrationon May 6, 2021 at 3:13 am
In just over a year, 14 vaccines have been approved for COVID-19, but in the past century, only one vaccine has been approved for tuberculosis—a clear example of neglect of a disease that ...
- Giving 2 Doses Of Different COVID-19 Vaccines Could Boost Immune Responseon May 5, 2021 at 7:11 pm
Using two different COVID-19 vaccines is a bit like giving the immune system two pictures of the virus, maybe one face-on and one in profile.
via Bing News